Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway. — CFSMEATLAS
Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway.
Kielland, Anne, Liu, Jing, Jason, Leonard A · Journal of health psychology · 2023 · DOI
Quick Summary
This study surveyed 660 people with ME/CFS in Norway to understand how different diagnostic criteria and symptoms affect their experiences with treatments and healthcare services. Most patients reported that available interventions had little benefit or made them feel worse. The researchers found that post-exertional malaise (a hallmark symptom where activity makes fatigue and other symptoms worse) was strongly linked to how patients tolerated different treatments, suggesting this symptom should be a key consideration when recommending interventions.
Why It Matters
This study directly addresses gaps in evidence about which interventions are actually helpful or harmful from patients' perspectives, rather than relying solely on clinical assumptions. By highlighting post-exertional malaise as a key determinant of treatment tolerance, it provides empirical support for reconsidering current treatment approaches and developing safer, more personalized interventions for ME/CFS patients.
Observed Findings
Most surveyed patients perceived available interventions as having low-to-negative health effects overall.
Post-exertional malaise (PEM) severity was strongly associated with how patients experienced and tolerated various interventions.
Responses to key interventions differed significantly between patient subgroups defined by different diagnostic criteria.
Patient experiences varied substantially, suggesting one-size-fits-all treatment approaches are inadequate.
Inferred Conclusions
Post-exertional malaise should be a central consideration when evaluating intervention safety and patient suitability, and may serve as a useful screening tool for predicting treatment tolerance.
Current mainstream interventions are perceived by most ME/CFS patients as ineffective or harmful, indicating a critical need for redesigned, evidence-based approaches.
Diagnostic criteria matter for some aspects of patient experience, but PEM appears to be a stronger individual predictor than diagnostic classification alone.
A 'do-no-harm' principle should guide all clinical management of ME/CFS given the absence of proven curative treatments.
Remaining Questions
What specific interventions were most frequently perceived as harmful, and what are the mechanisms behind negative patient experiences?
What This Study Does Not Prove
This study documents patient-perceived effects of interventions but does not establish objective clinical outcomes or prove causation—perceived benefit does not necessarily equal measurable physiological improvement. The cross-sectional design cannot determine whether interventions caused poor outcomes or whether patients with worse symptoms naturally rated them more negatively. Results are specific to Norway's healthcare context and may not generalize to other healthcare systems.
Do objective clinical measures correlate with patient-perceived intervention effects, or do they diverge significantly?
How do healthcare system factors (funding, provider training, available services) in Norway compare to other countries, and would findings generalize internationally?
What evidence-based, harm-preventive interventions could be developed that account for PEM tolerance thresholds in different patient subgroups?